This trial is active, not recruiting.

Condition rectal cancer
Treatments oxaliplatin and 5-fu based preoperative chemoradiation, chemoradiation
Phase phase 2
Sponsor Oslo University Hospital
Start date September 2005
End date December 2016
Trial size 150 participants
Trial identifier NCT00278694, Eudractnr 2005-000024-16, S-05059


Oxaliplatin and 5FU based preoperative chemoradiation in rectal cancer.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation non-randomized
Endpoint classification safety/efficacy study
Intervention model single group assignment
Masking open label
Primary purpose treatment
oxaliplatin and 5-fu based preoperative chemoradiation

Primary Outcomes

Safety profile
time frame:
Number of patients obtaining pCR
time frame:

Secondary Outcomes

Clinical, radiological and molecular response to treatment
time frame:

Eligibility Criteria

Male or female participants at least 18 years old.

Rectal cancer

Additional Information

Official title Oxaliplatin and 5-FU Based Preoperative Chemoradiation
Description Effect of treatment, safety profile and quality of life scorings.
Trial information was received from ClinicalTrials.gov and was last updated in November 2014.
Information provided to ClinicalTrials.gov by Oslo University Hospital.